Janney Montgomery Scott LLC grew its position in Revvity Inc. (NYSE:RVTY - Free Report) by 39.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,998 shares of the company's stock after purchasing an additional 3,107 shares during the quarter. Janney Montgomery Scott LLC's holdings in Revvity were worth $1,164,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Assetmark Inc. raised its stake in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after purchasing an additional 259 shares in the last quarter. Optiver Holding B.V. acquired a new stake in Revvity during the fourth quarter worth approximately $33,000. Quarry LP increased its stake in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after acquiring an additional 95 shares during the period. Millstone Evans Group LLC acquired a new position in Revvity in the 4th quarter valued at $38,000. Finally, Vermillion Wealth Management Inc. bought a new stake in shares of Revvity during the 4th quarter valued at $41,000. Institutional investors own 86.65% of the company's stock.
Revvity Price Performance
Shares of NYSE:RVTY traded down $1.01 during trading on Friday, hitting $97.78. 1,331,016 shares of the company were exchanged, compared to its average volume of 968,598. Revvity Inc. has a 1-year low of $87.70 and a 1-year high of $129.50. The company has a market capitalization of $11.53 billion, a P/E ratio of 41.61, a price-to-earnings-growth ratio of 2.39 and a beta of 0.97. The company has a quick ratio of 2.99, a current ratio of 3.58 and a debt-to-equity ratio of 0.41. The business's 50 day moving average is $93.36 and its 200-day moving average is $105.37.
Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.96 by $0.05. The firm had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The business's quarterly revenue was up 2.3% on a year-over-year basis. During the same period last year, the company earned $0.98 earnings per share. Equities analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current year.
Revvity Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is currently 11.91%.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. JPMorgan Chase & Co. decreased their price target on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and dropped their target price for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. Raymond James Financial reiterated an "outperform" rating and set a $120.00 price target (down previously from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Wells Fargo & Company decreased their price objective on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Finally, The Goldman Sachs Group cut their target price on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Four investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Revvity currently has an average rating of "Moderate Buy" and an average price target of $123.64.
Get Our Latest Stock Report on RVTY
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Featured Articles
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
